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Abstract
BACKGROUND  -:  Atherosclerosis  and  vascular  remodeling  after  injury  are  driven  by
inflammation and mononuclear cell  infiltration.  Extracellular  RNA (eRNA) has recently been
implicated to become enriched at sites of tissue damage and to act as a proinflammatory
mediator. Here, we addressed the role of eRNA in high-fat diet-induced atherosclerosis and
neointima formation after injury in atherosclerosis-prone mice. METHODS AND RESULTS -: The
presence of eRNA was revealed in atherosclerotic lesions from high-fat diet-fed low-density
lipoprotein receptor-deficient (Ldlr) mice in a time-progressive fashion. RNase activity in plasma
increased within the first 2 weeks (44±9 versus 70±7 mU/mg protein; P=0.0012), followed by a
decrease to levels below baseline after 4 weeks of high-fat diet (44±9 versus 12±2 mU/mg
protein;  P<0.0001).  Exposure of  bone marrow-derived macrophages to eRNA resulted in a
concentration-dependent upregulation of the proinflammatory mediators tumor necrosis factor-
α,  arginase-2,  interleukin-1β,  interleukin-6,  and  interferon-γ.  In  a  model  of  accelerated
atherosclerosis after arterial injury in apolipoprotein E-deficient (ApoE) mice, treatment with
RNase1 diminished the increased plasma level of eRNA evidenced after injury. Likewise, RNase1
administration reduced neointima formation in comparison with vehicle-treated ApoE controls
(25.0±6.2 versus 46.9±6.9×10 μm, P=0.0339) and was associated with a significant decrease
in plaque macrophage content. Functionally, RNase1 treatment impaired monocyte arrest on
activated smooth muscle cells under flow conditions in vitro and inhibited leukocyte recruitment
to  injured  carotid  arteries  in  vivo.  CONCLUSIONS  -:  Because  eRNA  is  associated  with
atherosclerotic  lesions  and  contributes  to  inflammation-dependent  plaque  progression  in
atherosclerosis-prone mice, its targeting with RNase1 may serve as a new treatment option
against atherosclerosis. © 2013 American Heart Association, Inc.
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